Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology SocietyAlexander R. Lyon, Daniel J. Lenihan, Teresa López‐Fernández et al.|European Journal of Heart Failure|2020Cited by 767
Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic EffectsJoerg Herrmann, Joshua D. Mitchell, Ana Barac et al.|JAMA Oncology|2025Cited by 10
A call to action: improving access to cardiac MRI for diagnosis of immune checkpoint inhibitor related myocarditis in low and middle income countriesAruni Ghose, Arjun K. Ghosh, Abhinav Kandala et al.|Cardio-Oncology|2025Cited by 1